Determinants and clinical impact of time to plasma exchange in patients with immune thrombotic thrombocytopenic purpura
Our data show that different factors contribute to the interval between symptom onset and presentation versus the time between presentation and initiation of therapy in iTTP.
Authors
- Brian J. Carney (ORCID: https://orcid.org/0000-0003-0954-789X)
- Sean R. Stowell (ORCID: https://orcid.org/0000-0002-1130-9551)
- Robert S. Makar (ORCID: https://orcid.org/0000-0001-7420-2631)
- Julia Collins (ORCID: https://orcid.org/0000-0003-4268-6007)
- Lynne Uhl (ORCID: https://orcid.org/0000-0002-8868-7198)
- Kristen N. Ruby (ORCID: https://orcid.org/0000-0001-7089-1046)
- Arielle L. Langer (ORCID: https://orcid.org/0000-0002-0301-7073)
- Pavan K. Bendapudi (ORCID: https://orcid.org/0000-0002-0754-7688)
- Sunny Dzik (ORCID: https://orcid.org/0000-0003-3844-4371)
- Ishan Tatake (ORCID: https://orcid.org/0009-0004-1558-021X)
- Shelby C. Wilkinson
Institutions
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Mayo Clinic (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1111/trf.18291
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health